Is ALNEV.PA a good investment?
As of 2025-03-20, the Fair Value of Neovacs SA (ALNEV.PA) is -656.50 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.05 EUR, the upside of Neovacs SA is -1,215,850.00%. This means that ALNEV.PA is not a good investment.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -7.55 | -6.14 | -11.84 | -3.55 | -8.74 | -7.56 |
| YoY growth | 29.98% | 18.62% | -92.71% | 70.02% | -146.40% | -24.10% |
| Market Cap (mil) | 0.01 |
| P/E | |
| Forward P/E |
| EPS | -131.30 |
| Avg earnings growth rate | -24.10% |
| TTM earnings | -35.45 |